Loading...
Insulin
India Pharmaceutical Trade Intelligence
Who Supplies Insulin to India from MALAYSIA
India's insulin imports from MALAYSIA total $3.9M across 101 shipments from 2 foreign suppliers. BIOCON SDN BHD leads with $3.0M in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include BIOCON BIOLOGICS LIMITED. This corridor reflects India's pharmaceutical import demand for insulin — a concentrated sourcing relationship with select suppliers from MALAYSIA.
Top foreign suppliers (MALAYSIA) — Ranked by import value
BIOCON SDN BHD is the leading Insulin supplier from MALAYSIA to India, with import value of $3.0M across 99 shipments. The top 5 suppliers — BIOCON SDN BHD, XXOCOXXSDNXXHD — collectively account for 100.0% of total import value from this origin.
Top foreign suppliers (MALAYSIA)
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | BIOCON SDN BHD | $3.0M | 99 | 75.7% |
| 2 | XXOCOXXSDNXXHD | $950.6K | 2 | 24.3% |
Showing top 2 of 2 foreign suppliers · Indian Customs (DGFT) · TransData Nexus
Top Indian buyers (importing from MALAYSIA)
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | BIOCON BIOLOGICS LIMITED | $2.3M | 10 | 57.7% |
| 2 | BIOCON BIOLOGICS INDIA LIMITED | $1.6M | 4 | 41.8% |
| 3 | MOLEX INDIA BUSINESS SERVICES PRIVATE LIMITED | $15.1K | 2 | 0.4% |
| 4 | BIONEEDS INDIA PRIVATE LIMITED | $3.1K | 76 | 0.1% |
| 5 | BIONEEDS INDIA PVT LTD | $356 | 9 | 0.0% |
Import Statistics
- Import Value
- $3.9M
- Shipments
- 101
- Foreign Suppliers
- 2
- Indian Buyers
- 5
- Avg. Shipment
- $38.7K
Other Insulin Import Origins
Frequently Asked Questions — Insulin Imports from MALAYSIA
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
QWho are the top Insulin suppliers from MALAYSIA to India?
The top Insulin suppliers from MALAYSIA to India include BIOCON SDN BHD, XXOCOXXSDNXXHD. The leading supplier is BIOCON SDN BHD with import value of $3.0M USD across 99 shipments. India imported Insulin worth $3.9M USD from MALAYSIA in total across 101 shipments.
QHow much Insulin does India import from MALAYSIA?
India imported Insulin worth $3.9M USD from MALAYSIA across 101 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
QWho are the main Indian buyers of Insulin from MALAYSIA?
The main Indian buyers of Insulin sourced from MALAYSIA include BIOCON BIOLOGICS LIMITED, BIOCON BIOLOGICS INDIA LIMITED, MOLEX INDIA BUSINESS SERVICES PRIVATE LIMITED. The largest buyer is BIOCON BIOLOGICS LIMITED with $2.3M in imports across 10 shipments.
QWhat is the total value of Insulin imports from MALAYSIA to India?
The total value of Insulin imports from MALAYSIA to India is $3.9M USD, across 101 shipments and 2 foreign suppliers. Data source: Indian Customs (DGFT).
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
SS
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: MALAYSIA to India pharmaceutical import trade corridor identified from Indian Customs (DGFT) shipping bill records for Insulin.
- 2.Supplier/Buyer Matching: 2 foreign suppliers from MALAYSIA and 5 Indian buyers identified using company name normalization across customs records.
- 3.Value Aggregation: Total import value of $3.9M aggregated from 101 verified shipping bill records. All values reported in FOB USD as recorded by Indian Customs.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
101 Verified Shipments
2 suppliers, 5 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists